These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8877542)
1. The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria. Bowker KE; Wootton M; Holt HA; Reeves DS; MacGowan AP J Antimicrob Chemother; 1996 Aug; 38(2):271-81. PubMed ID: 8877542 [TBL] [Abstract][Full Text] [Related]
2. [Activity of trovafloxacin and ten other antimicrobials against gram negative anaerobic bacilli]. Chávez M; García López JL; Coronilla J; Bernal S; Valverde A; Martín Mazuelos E Rev Esp Quimioter; 1998 Dec; 11(4):349-52. PubMed ID: 9990149 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates. Ling TK; Liu EY; Cheng AF Chemotherapy; 1999; 45(1):22-7. PubMed ID: 9876206 [TBL] [Abstract][Full Text] [Related]
4. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections. Hoogkamp-Korstanje JA J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498 [TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes. Aldridge KE; Ashcraft D; Bowman KA Antimicrob Agents Chemother; 1997 Feb; 41(2):484-7. PubMed ID: 9021215 [TBL] [Abstract][Full Text] [Related]
6. Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods. Ednie LM; Credito KL; Khantipong M; Jacobs MR; Appelbaum PC J Antimicrob Chemother; 2000 May; 45(5):633-8. PubMed ID: 10797085 [TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates. Cunha BA; Qadri SM; Ueno Y; Walters EA; Domenico P J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067 [TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of trovafloxacin (CP-99,219) against 434 bacterial strains: comparative study with other fluoroquinolones]. Tali-Maamar H; Tebbal S; Rahal K Arch Inst Pasteur Alger; 1998; 62():52-61. PubMed ID: 11256319 [TBL] [Abstract][Full Text] [Related]
9. The chemistry and biological profile of trovafloxacin. Brighty KE; Gootz TD J Antimicrob Chemother; 1997 Jun; 39 Suppl B():1-14. PubMed ID: 9222064 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of 497 clinical isolates of gram-negative anaerobes to trovafloxacin and eight other antibiotics. Rotimi VO; Mokaddas EM; Jamal WY; Khodakhast FB; Verghese TL; Sanyal SC J Chemother; 1999 Oct; 11(5):349-56. PubMed ID: 10632380 [TBL] [Abstract][Full Text] [Related]
11. Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates. Seifert H Zentralbl Bakteriol; 1998 Dec; 288(4):509-18. PubMed ID: 9987189 [TBL] [Abstract][Full Text] [Related]
12. The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria. Sefton AM; Maskell JP; Rafay AM; Whiley A; Williams JD J Antimicrob Chemother; 1997 Jun; 39 Suppl B():57-62. PubMed ID: 9222071 [TBL] [Abstract][Full Text] [Related]
13. Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria. MacGowan AP; Bowker KE; Holt HA; Wootton M; Reeves DS J Antimicrob Chemother; 1997 Oct; 40(4):503-9. PubMed ID: 9372419 [TBL] [Abstract][Full Text] [Related]
14. Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria. Shonekan D; Handwerger S; Mildvan D J Antimicrob Chemother; 1997 Mar; 39(3):405-9. PubMed ID: 9096191 [TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro activity of trovafloxacin against gram-positive and gram-negative organisms with quinolones and beta-lactam antimicrobial agents. Dembry LM; Roberts JC; Schock KD; Marino SP; Farrel PA; Andriole VT Diagn Microbiol Infect Dis; 1998 May; 31(1):301-11. PubMed ID: 9597391 [TBL] [Abstract][Full Text] [Related]
16. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria. Wexler HM; Molitoris E; Molitoris D; Finegold SM Antimicrob Agents Chemother; 1996 Sep; 40(9):2232-5. PubMed ID: 8878617 [TBL] [Abstract][Full Text] [Related]
18. Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media. Hecht DW; Osmolski JR Clin Infect Dis; 1996 Dec; 23 Suppl 1():S44-50. PubMed ID: 8953106 [TBL] [Abstract][Full Text] [Related]